West Pharmaceutical Services, Inc. (WST) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $340.41 --0%
Revenue Growth %: +9.5%
Financial Fact:
Net income: 37.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +9.5%
Financial Fact:
Net income: 37.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.38, $0.03 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $346.8 million versus the consensus estimate of $340.9 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
- Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF720 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
